AltheaDx: $30 Million Series C Financing

AltheaDx, developer of a pharmacogenetics product testing portfolio, in its $30 million Series C financing.

Related Contacts
Ken Rollins Partner, San Diego
Related Practices & Industries

Emerging Companies Venture Capital